FORE US Bio Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2025 | $70 M | No. 2 | $50 to $250 million | equity | SEC | |
| Aug 2023 | $62 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
FORE US Bio Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2026).
SEC Form D · Jul 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2026
That is all the official record says: FORE US Bio Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of FORE US Bio Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 20 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Michael Byrnes | Chief Financial Officer | Jul 2026 |
| William Hinshaw | Executive officer | Jul 2026 |
| Jeff Sacher | Chief Financial Officer | Aug 2023 |
| Matthew Ros | Chief Executive Officer, President and Secretary | Aug 2023 |
| Chandra Leo | Director | Jul 2026 |
| Dieter Weinand | Director | Jul 2026 |
| Erez Chimovits | Director | Jul 2026 |
| Giovanni Mariggi | Director | Jul 2026 |
| Kim Blackwell | Director | Jul 2026 |
| Rajeev Dadoo | Director | Jul 2026 |
| William Hinshaw | Director | Jul 2026 |
| Matthew Foy | Director | May 2025 |
| Michael Byrnes | Director | May 2025 |
| Matthew Ros | Chief Executive Officer, President and Secretary | Aug 2023 |
| Meenu Chhabra Karson | Director | Aug 2023 |
| Michal Silverberg | Director | Aug 2023 |
| Roberto De Ponti | Director | Aug 2023 |